Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Non-steroidal anti-inflammatory agents. Prospects].

¹Service de Rhumatologie, Hôpital Henri Mondor, Creteil.

Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires

|April 30, 1989

Summary

Non-steroidal anti-inflammatory agents (NSAIAs) vary in efficacy and side effects. Improving NSAIA tolerance and risk assessment is crucial due to potential adverse effects, especially on reproduction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Overcoming barriers in biomarker testing. Letter to the Editor regarding: 'ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe', by A. Bayle et al.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Same author

Health claims assessment in the field of joint and cartilage: a consensus viewpoint of the Group for the Respect of Ethics and Excellence in Science.

Current medical research and opinion·2012

Same author

Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2011

Same author

Primary osteoarthritis of hip, knee, and hand in relation to occupational exposure.

Occupational and environmental medicine·2005

Same author

Measuring the contribution of pharmacological treatment to advice to stay active in patients with subacute low-back pain: a randomised controlled trial.

Pharmacoepidemiology and drug safety·2005

Same author

Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis.

Osteoarthritis and cartilage·2005

Area of Science:

Pharmacology
Toxicology

Context:

Numerous non-steroidal anti-inflammatory agents (NSAIAs) are available, exhibiting significant inter-patient variability in efficacy and adverse effects.
Cyclo-oxygenase inhibition was the primary understanding of anti-inflammatory agent mechanisms for decades.
Improving drug tolerance is a key driver for developing new pharmacological agents.

Purpose:

To highlight the need for enhanced methods to evaluate NSAIA tolerance before market release.
To emphasize that all NSAIAs present significant adverse effect challenges.
To underscore the multifaceted nature of NSAIA risk assessment.

Summary:

The wide availability of NSAIAs is driven by patient-specific efficacy and sensitivity to adverse effects.
While cyclo-oxygenase inhibition is a known mechanism, improving NSAIA tolerance is a primary research goal.
Evaluating NSAIA tolerance requires improvement, as all carry risks influenced by molecular properties, toxicology (including reproductive effects), treatment duration, and patient factors.

Impact:

Enhanced tolerance and improved risk assessment methods are needed for safer NSAIA use.
Understanding the factors influencing NSAIA risk can lead to better patient outcomes.
This research underscores the importance of comprehensive toxicological evaluation for anti-inflammatory drugs.

Related Experiment Videos